<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Walker-Warburg syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WWS</z:e>) is an <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> condition characterised by <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo>, structural brain defects, and <z:mp ids='MP_0002092'>eye malformations</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Typical brain abnormalities are <z:hpo ids='HP_0000238'>hydrocephalus</z:hpo>, <z:hpo ids='HP_0001339'>lissencephaly</z:hpo>, <z:hpo ids='HP_0001274'>agenesis of the corpus callosum</z:hpo>, fusion of the hemispheres, <z:hpo ids='HP_0001321'>cerebellar hypoplasia</z:hpo>, and neuronal overmigration, which causes a cobblestone cortex </plain></SENT>
<SENT sid="2" pm="."><plain>Ocular abnormalities include <z:hpo ids='HP_0000518'>cataract</z:hpo>, <z:hpo ids='HP_0000568'>microphthalmia</z:hpo>, <z:hpo ids='HP_0000557'>buphthalmos</z:hpo>, and <z:hpo ids='HP_0000659'>Peters anomaly</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WWS</z:e> patients show defective O-glycosylation of alpha-dystroglycan (alpha-DG), which plays a key role in bridging the cytoskeleton of muscle and <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> cells with extracellular matrix proteins, important for muscle integrity and neuronal migration </plain></SENT>
<SENT sid="4" pm="."><plain>In 20% of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WWS</z:e> patients, hypoglycosylation results from mutations in either the protein O-mannosyltransferase 1 (POMT1), fukutin, or fukutin related protein (FKRP) genes </plain></SENT>
<SENT sid="5" pm="."><plain>The other genes for this highly <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> disorder remain to be identified </plain></SENT>
<SENT sid="6" pm="."><plain>OBJECTIVE: To look for mutations in POMT2 as a cause of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WWS</z:e>, as both POMT1 and POMT2 are required to achieve protein O-mannosyltransferase activity </plain></SENT>
<SENT sid="7" pm="."><plain>METHODS: A candidate gene approach combined with homozygosity mapping </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Homozygosity was found for the POMT2 locus at 14q24.3 in four of 11 consanguineous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WWS</z:e> families </plain></SENT>
<SENT sid="9" pm="."><plain>Homozygous POMT2 mutations were present in two of these families as well as in one patient from another cohort of six <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WWS</z:e> families </plain></SENT>
<SENT sid="10" pm="."><plain>Immunohistochemistry in muscle showed severely reduced levels of glycosylated alpha-DG, which is consistent with the postulated role for POMT2 in the O-mannosylation pathway </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: A fourth causative gene for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WWS</z:e> was uncovered </plain></SENT>
<SENT sid="12" pm="."><plain>These genes account for approximately one third of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WWS</z:e> cases </plain></SENT>
<SENT sid="13" pm="."><plain>Several more genes are anticipated, which are likely to play a role in glycosylation of alpha-DG </plain></SENT>
</text></document>